Brilliant Violet 510™ anti-mouse CD23

Antibodies Single
Sony
B3B4
Flow Cytometry
Rat IgG2a, κ
Mouse
Complex of IgE with Fcε receptor isolated from the mouse B hybridoma cell line O1.2B2
50 µg
1108115
$290.00

Description

CD23 is a 45 kD protein also known as low affinity IgE Fc receptor, FcεRII, BLAST-2, Ly-42, or B6. It is a member of the Ig family, expressed on conventional B (but not B-1) cells and follicular dendritic cells. CD23 responds to high levels of IgE by downregulating IgE secretion.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 microg per million cells in 100 microL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 510™ excites at 405 nm and emits at 510 nm. The bandpass filter 510/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 510™ is a trademark of Sirigen Group Ltd.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

References

1. Waldschmidt TJ, et al. 1988. J. Immunol. 140:2148. (IP)
2. Rao M, et al. 1987. J. Immunol. 138:1845. (Block)
3. Oshiba A, et al. 1997. J. Immunol. 159:4056. (Block)
4. Dasic G, et al. 1999. Eur. J. Immunol. 29:2957. (Block)
5. Maeda K, et al. 1992. J. Immunol. 148:2340. (IHC)
6. Craig VJ, et al. 2011. Cancer Res. 71:3616. PubMed